South Plains Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Hold
14,247
0.18% 103
2026
Q1
$400K Sell
14,247
-552
-4% -$14.7K 0.23% 99
2025
Q4
$368K Sell
14,799
-50
-0.3% -$1.26K 0.22% 100
2025
Q3
$378K Hold
14,849
0.24% 97
2025
Q2
$360K Hold
14,849
0.25% 94
2025
Q1
$376K Sell
14,849
-1,529
-9% -$40K 0.29% 90
2024
Q4
$434K Buy
+16,378
New +$444K 0.33% 77

Other funds holding PFE

South Plains Financial's PFE Position: Q2 2026 in Review

South Plains Financial held its Pfizer (PFE) position steady in Q2 2026 at 14,247 shares worth $343K. The position accounts for 0.18% of the portfolio, ranked #103.

South Plains Financial first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $434K in Q4 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • South Plains Financial held 14,247 shares of Pfizer worth $343K as of Q2 2026.
  • South Plains Financial left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.18% of South Plains Financial's portfolio in Q2 2026, its #103 holding.
  • South Plains Financial first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • South Plains Financial's Pfizer position peaked at $434K in Q4 2024.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on South Plains Financial's 13F filing for Q2 2026, filed 13 Aug 2026.